CLINICAL SIGNIFICANCE OF THE VEGFR-2 IN THE TUMORS AND BLOOD SERA OF THE BREAST CANCER PATIENTS

• Príomhchruthaitheoirí: E. A. Kim (Údar), A. M. Platova (Údar), I. V. Visotzkaya (Údar), E. S. Gershteyn (Údar), V. P. Letyagin (Údar), N. E. Kushlinskiy (Údar), E. E. Mironova (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: ABV-press, 2014-09-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

The analysis of the changes of the content of the angiogenic factor VEGFR-2 in the cytosol of the tumor and blood sera of the 30 breast can- cer patients determined by immunoenzyme method during neoadjuvant therapy is given. Likewise the correlation of this index with the main clinicomorphological c...